Endocrine Abstracts

A large population-based cohort of “diagnosed” primary hyperparathyroidism (PHPT) (n=2709) was established, 1997–2006, in Tayside, Scotland. We have previously reported on an increasing prevalence and increased risks of mortality and morbidity associated with these patients. In the course of the PEARS, a group of “possible” PHPT cases (n=2950) defined as having persistently elevated serum calcium over several months to years but with no P...

Context: Rising evidence of the increased risk in mild PHPT suggests that serum calcium, which has been a main surgical criterion, maybe not an accurate indicator of disease severity or at least, not a reliable predictive factor of its long-term consequences. This study aims to identify the best biochemical predictor of adverse outcomes in untreated PHPT.Outcome measures and methods: Primary outcomes considered were all-cause mortality, fatal and non-fat...

Clinical Endocrinology 2013 79 27–34. DOI: 10.1111/cen.12206...

The prevalence of primary hyperparathyroidism (PHPT) is increasing and the majority (over 85%) are now asymptomatic and remain untreated. In order to know whether or not they can be left safely without surgery, issues on disease progression need to be addressed. We aimed to update the natural history of PHPT, with a focus of serum calcium progression in mild untreated patients, selected from a large pre-defined cohort of PHPT in Tayside, Scotland. Possible predictors of progre...

Previous studies have reported increased cardiovascular disease, fractures and renal stones for patients with primary hyperparathyroidism (PHPT). These studies are mainly based on patients referred to specialist centres or unselected PHPT patients. We specifically aimed to assess the risk for patients ‘mild’ PHPT, in whom treatment is usually not recommended. Using the unique patient identifier, which is used for all medical contacts in Tayside, data linkage of recor...